#Airway or Lung Stents Market Size

[amrutatbrc1]

Pulmonology Devices Market 2024 : Industry Analysis, Trends, Segmentation, Regional Overview And Forecast 2033

Overview and Scope Pulmonology devices are medical instruments and equipment used in the diagnosis, treatment, and management of respiratory system conditions and diseases. These devices play a crucial role in assessing lung function, monitoring respiratory health, providing therapeutic interventions, and supporting patients with respiratory disorders.

Sizing and Forecast The pulmonary devices market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to rising incidence of chronic respiratory diseases, growing shift towards preventive healthcare, increase in adoption of pulmonology devices, surge in incidence of diseases requiring endoscopic ultrasound procedures, increase in geriatric population.

The pulmonary devices market size is expected to see rapid growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rise in prevalence of respiratory diseases, rising air pollution levels, growth in home healthcare, growing awareness and early diagnosis, expansion of healthcare infrastructure. Major trends in the forecast period include integration of artificial intelligence, growth of telemedicine and remote monitoring, advancements in portable and wearable devices, use of robotic technology in less-invasive diagnostic procedures, increase in home care services.

Order your report now for swift delivery, visit the link: https://www.thebusinessresearchcompany.com/report/pulmonology-devices-global-market-report

Segmentation & Regional Insights The pulmonology devices market covered in this report is segmented –

1) By Product Type: Endobronchial Ultrasound (EBUS) Needles, Pulmonary Biopsy Devices, Airway Stents, Single-Use Bronchoscopes, Other Product Types 2) By Indication: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Tracheal And Bronchial Stenosis, Foreign Body Extraction, Other Indications 3) By End-User: Pulmonology Clinics, Hospitals, Ambulatory Surgical Centers

North America was the largest region in the pulmonology devices market in 2023. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=16772&type=smp

Major Driver Impacting Market Growth The rise in the prevalence of respiratory diseases is expected to propel the growth of the pulmonology devices market going forward. Respiratory diseases are a group of medical conditions that affect the organs and tissues involved in breathing, including the airways, lungs, and respiratory muscles. The cases of respiratory diseases are occurring due to rising air pollution, smoking, and occupational hazards. Pulmonology devices aid in respiratory disease management by enabling accurate diagnosis, continuous monitoring, and effective treatment through tools like spirometers, inhalers, pulse oximeters, and ventilators, ultimately improving patient outcomes and quality of life. For instance, according to the Scottish Public Health Observatory, a Scotland-based public health agency, COPD rates began rising in 2021-22 as the effects of COVID-19 lessened. The rate among males rose from 83.2 to 97.6 cases per 100,000, while it increased from 72.6 to 97.3 among females. Therefore, the rise in the prevalence of respiratory diseases is driving the growth of the pulmonology devices market.

Key Industry Players Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX

The pulmonology devices market report table of contents includes:

1. Executive Summary

2. Pulmonology Devices Market Characteristics

3. Pulmonology Devices Market Trends And Strategies

4. Pulmonology Devices Market - Macro Economic Scenario

5. Global Pulmonology Devices Market Size and Growth ..........

32. Global Pulmonology Devices Market Competitive Benchmarking

33. Global Pulmonology Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pulmonology Devices Market

35. Pulmonology Devices Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[themarketupdate]

Airway Stent / Lung Stent Market to Witness Excellent Revenue Growth Owing to Rapid Increase in Demand

The airway stents is the tube-like structure with with a hollow lumen is introduced in the respiratory airway to open the narrowed airway passage. It is also known as the tracheobronchial prostheses that supports the airway passage. Airway stenting is the palliative therapy for the population suffering from central airway obstruction (CAO) due to malignant lesion, obstructive tracheobronchial diseases, tracheobronchomalacia, relapsing polychondritis, and other reasons. External compression of the airway passage due to lymph nodes or metastatic disease results in obstruction of central airway pipe. These are available in rigid and flexible materials such as metals and silicon.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/33090-global-airway-stent-lung-stent-market?utm_source=Organic&utm_medium=Vinay

Latest released the research study on Global Airway Stent / Lung Stent Market, offers a detailed overview of the factors influencing the global business scope. Airway Stent / Lung Stent Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Airway Stent / Lung Stent The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Boston Scientific (United States),  BD (United States), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Teleflex (United States), Merit Medical Systems (United States), Cook Group (United States), Novatech SA (France), Endo-Flex (Germany), M.I. Tech (South Korea),

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

sales@advancemarketanalytics.com

[mysticalfungalaxy]

Non-Vascular Stents Market is expected to be valued at US$ 1.9 billion by 2032 | FMI

The Non-Vascular Stents Market is expected to grow at a CAGR of 4.5% over the anticipated timeframe. (2022 – 2032). In 2022, it is projected that the industry will be worth US$ 1.21 billion, and by 2032, it will be worth US$ 1.9 billion.

The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth.

To learn more about this report @ https://www.futuremarketinsights.com/reports/non-vascular-stents-market

Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient’s safety in jeopardy. Such surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, encouraging many to opt for the same.

Furthermore, patients are less likely to contract hospital-acquired illnesses like bloodstream infections and urinary tract infections if they stay in the hospital for a shorter period of time, in turn, propelling the demand for non-vascular stents.

The most visible and prominent factor spiking the sales of non-vascular stents is a surge in cases of chronic obstructive pulmonary disease (COPD), which is caused by smoking, lung cancer, tracheobronchial malacia, and chemical exposure.

Numerous innovations are taking place in the non-vascular stents market as new medical devices are developed to track gastrointestinal tract, urinary tract, and airway tract.

Non-vascular stents market trends are fostered by rising healthcare spending in developing countries, government and private insurance companies’ helpful medical reimbursement policies, and the proliferation of hospitals and ambulatory surgical centers.

The non-vascular stents market is segmented by product type and by region, where by product type, the market is divided into gastrointestinal stents, pulmonary stents, urological stents, and others.

Non-vascular implants are medical devices designed to keep open and support non-vascular structures within the body. Unlike vascular stents, which are used to treat blockages in blood vessels, non-vascular stents are used to treat a variety of conditions in other parts of the body.

Key Takeaways:

Based on product type, the urological stents segment is likely to dominate the non-vascular stents market with a CAGR of 4.3% through 2032.

The US non-vascular stents market is expected to capture a sizeable non-vascular stents market share accounting for around US$659.1 million by 2032.

By 2032, the UK non-vascular stents market is expected to be valued at US$ 80.6 million, growing at a CAGR of 3.3%.

With a CAGR of 3.6% during the forecast period, China non-vascular stents market size is predicted to be apprised at US$ 128.1 million by 2032.

The Japan non-vascular stents market, with a CAGR of 3.9%, is projected to garner a worth of US$ 109.8 million by 2032.

Key Players:

Medtronic plc.

Glaukos Corporation

Boston Scientific Corporation

ELLA – CS, s.r.o.

CONMED Corporation

Key Segments

By Product:

Gastrointestinal Stents

Biliary

Duodenal

Colonic

Pancreatic

Oesophageal Stents

Pulmonary Stents

Silicone Airway

Metallic Airway

Urological Stents

Others

[sabalevaishali]

Airway or Lung Stents Market is estimated to value over USD 125 Million by 2029 end and register a CAGR of over 6.2% during the forecast period 2020 to 2029.

Based on the type of product, the market is bifurcated into tracheobronchial stents and laryngeal stents. The tracheobronchial stents segment dominates the market owing to a rising number of patients suffering from lung cancer and other chronic respiratory diseases. On the basis of the type of material, the market is categorised as metal stents, nitinol stents, stainless steel stents, silicone stents, hybrid stents and other stents. Metal stents segment dominated the market in 2018 owing to the advantages associated with them like thinner walls in comparison with silicone lung stents, ease of insertion, ability to adapt the twisted airway and a lower risk of migration or dislodgement.

[aishavass]

On the other hand, Asia Pacific is likely to emerge as the most lucrative regional Airway Stent/Lung Stent market on account of improving reimbursement...

[alliedanalytics]

Companies Competing in the Airway Stent/Lung Stent Market

Tracheobronchial (airway) stents are those devices utilized to splint narrowed airways open. The narrow or stenotic, airways result from abnormal granulation tissue, metastatic cancers, lung cancer, tuberculosis, infections, lymphoma, or other inflammatory diseases. Stents are somewhat cylindrical in shape and also can be deployed by a bronchoscope. Furthermore, there are various materials that can be used in stents, with different stents having different disease indications. Airway stents can be of two types, permanent or removable. These can be used after the pulmonary physician applies electrocautery, laser, balloon dilatation, or APC to increase the size of airway narrowing. By placing a stent, the airways remain open, allowing adequate airflow and the standard passage of secretions.

 Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/11633

 COVID-19 scenario analysis:

The need for care of infected population by assisting with management of the infection with medical supplies is increasing. The respiratory support devices such as the atomizers, life-support machine, the oxygen generators, and the monitors are among the majorly used medical devices in clinical treatment.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Rise in prevalence of respiratory disorders globally and increase in preference for minimally invasive procedures drives the market growth. Furthermore, surge in demand for customized lung stents with the development of biodegradable and drug-eluting stents offers lucrative growth opportunities for the players in the industry. However, rise in availability of alternative treatment may hinder the growth of the industry in the near future.

New product advancements to flourish the market

The launch of new products according to the key market players would help the market gain a lucrative growth in the forecast period. For instance, in January 2020, the U.S. Food and Drug Administration (FDA) had cleared the patient-specific airway stents. The stents are used to help in keeping open the airways of patients who are suffering with serious breathing disorders, such as those caused by tumors, inflammation, trauma or other masses. Until now, the patient-specific devices were being implanted under FDA’s

Surge in mergers and acquisitions to boost the market

The growth in the number of mergers and acquisition would propel the market in the coming years. For instance, in June 2018, Cook Medical had partnered with Taewoong Medical in order to distribute a selection of stents in to the United States. The new partnership includes the Niti-S through the Scope (TTS) Esophageal Stent, which is the flagship product of the South Korean company’s Niti-S Self-Expandable line of metal GI stents. Cook Medical will begin distributing the Taewoong portfolio.

Key benefits of the report:

This     study presents the analytical depiction of the global airway stent/lung     stent industry along with the current trends and future estimations to     determine the imminent investment pockets.

The     report presents information related to key drivers, restraints, and     opportunities along with detailed analysis of the global Airway Stent/Lung     Stent market share.

The     current market is quantitatively analyzed from 2020 to 2027 to highlight     the global Airway Stent/Lung Stent market growth scenario.

Porter’s     five forces analysis illustrates the potency of buyers & suppliers in     the market.

The     report provides a detailed global Airway Stent/Lung Stent market analysis     based on competitive intensity and how the competition will take shape in     coming years.

 Access Full Report Summary: https://www.alliedmarketresearch.com/airway-stent-lung-stent-market-A11268

 About Us

 Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

 Contact:

 David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

[shubhambhosale1911-blog]

Global Airway or Lung Stents Market is estimated to value over USD 125 Million by 2029 end and register a CAGR of over 6.2% during the forecast period 2019 to 2029. 

Airway or lung stent is inserted into an airway to replace the damaged one to ensure that the lungs function normally.

[itssashasharma]

Airway Stent/Lung Stent Market is expected to reach $120 Million by 2024.

According to the new market research report " Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecast to 2024", published by MarketsandMarkets™, the Airway Stent/Lung Stent Market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. Factors such as the rise in the prevalence of lung cancer & chronic respiratory diseases and the growing preference of minimally invasive procedures are expected to drive the growth of the airway/lung stent market. The need for customized lungs stents and the ability to currently print the stents using 3D printing techniques are expected to create growth opportunities for this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890 The tracheobronchial stents segment is expected to account for the largest share of the Airway Stent/Lung Stent Market in 2019. Based on type, the Airway Stent/Lung Stent Market is categorized into tracheobronchial and laryngeal stents. In 2019, the tracheobronchial segment is expected to account for the largest share of the airway/lung stent market. The large share of this segment can be attributed to the high adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. By material, the metal stents segment is estimated to account for the largest share of the Airway Stent/Lung Stent Market in 2019. Based on the materials used to manufacture airway/lung stents, the market is segmented into metal, silicone, and hybrid stents. Certain advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment. The self-expandable stents segment is estimated to hold the largest share of the Airway Stent/Lung Stent Market in 2019. Based on the product, the Airway Stent/Lung Stent Market is segmented into expandable and non-expandable stents. Of this, the expandable stents segment is estimated to hold a larger share of the market in 2019, due to the higher preference of these stents by surgeons due to advantages such as easy insertion in bronchoscopy procedures, lower risks of stent-induced complications, small size, and their easy removal. Hospitals will account for the largest share of the Airway Stent/Lung Stent Market in 2019. Based on end user, the Airway Stent/Lung Stent Market is segmented into hospitals and ambulatory surgical centers. In 2019, the hospitals segment will dominate the airway/lung stents market. The growing number of hospitals, increasing cases of lung cancer & other chronic airway diseases treated in hospitals, growth in the healthcare sector in emerging economies, and the increasing out-of-pocket healthcare expenditure across the globe are the key factors driving the demand for airway/lung stents in hospitals. Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890 North America is expected to dominate the market in 2019 In 2019, North America is estimated to account for the largest share of the airway/lung stent market, followed by Europe. The dominant share of North America is attributed mainly to the presence of several large hospitals, robust healthcare infrastructure, rising prevalence of diseases, growing geriatric population, and the rising healthcare expenditure. The key players operating in the Airway Stent/Lung Stent Market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among

others.

[rahulg1122]

Airway Stent/Lung Stent Market Worth $120 Million by 2024

According to the new market research report "Airway Stent/Lung Stent Market by Type (Tracheal, Bronchial, Laryngeal Stent), Product (Non-Expandable, Self-Expandable Stents), Material (Metal (Nitinol, Stainless Steel), Silicone, Hybrid), End User (Hospitals, ASCs) - Global Forecast to 2024", published by MarketsandMarkets™, the Airway Stent/Lung Stent Market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. 

Browse in-depth TOC on "Airway Stent/Lung Stent Market"

137 – Tables

34 – Figures  

164 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32315890

Factors such as the rise in the prevalence of lung cancer & chronic respiratory diseases and the growing preference of minimally invasive procedures are expected to drive the growth of the airway/lung stent market. The need for customized lungs stents and the ability to currently print the stents using 3D printing techniques are expected to create growth opportunities for this market. 

The tracheobronchial stents segment is expected to account for the largest share of the Airway Stent/Lung Stent Market in 2019.

Based on type, the Airway Stent/Lung Stent Market is categorized into tracheobronchial and laryngeal stents. In 2019, the tracheobronchial segment is expected to account for the largest share of the airway/lung stent market. The large share of this segment can be attributed to the high adoption of tracheal and bronchial stents in the treatment of lung cancer and other chronic respiratory diseases.

By material, the metal stents segment is estimated to account for the largest share of the Airway Stent/Lung Stent Market in 2019.

Based on the materials used to manufacture airway/lung stents, the market is segmented into metal, silicone, and hybrid stents. Certain advantages associated with metal stents, such as ease of insertion, thinner walls as compared to silicone lung stents, a lower risk of dislodgment or migration, and ability to adapt to the twisted airway are driving the growth of this segment.

The self-expandable stents segment is estimated to hold the largest share of the Airway Stent/Lung Stent Market in 2019.

Based on the product, the Airway Stent/Lung Stent Market is segmented into expandable and non-expandable stents. Of this, the expandable stents segment is estimated to hold a larger share of the market in 2019, due to the higher preference of these stents by surgeons due to advantages such as easy insertion in bronchoscopy procedures, lower risks of stent-induced complications, small size, and their easy removal.

Hospitals will account for the largest share of the Airway Stent/Lung Stent Market in 2019.

Based on end user, the Airway Stent/Lung Stent Market is segmented into hospitals and ambulatory surgical centers. In 2019, the hospitals segment will dominate the airway/lung stents market. The growing number of hospitals, increasing cases of lung cancer & other chronic airway diseases treated in hospitals, growth in the healthcare sector in emerging economies, and the increasing out-of-pocket healthcare expenditure across the globe are the key factors driving the demand for airway/lung stents in hospitals.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=32315890

North America is expected to dominate the market in 2019

In 2019, North America is estimated to account for the largest share of the airway/lung stent market, followed by Europe. The dominant share of North America is attributed mainly to the presence of several large hospitals, robust healthcare infrastructure, rising prevalence of diseases, growing geriatric population, and the rising healthcare expenditure.

The key players operating in the Airway Stent/Lung Stent Market include Boston Scientific Corporation (US), Taewoong Medical Co., Ltd. (South Korea), Micro-Tech (Nanjing) Co., Ltd. (China), Novatech SA (France), Boston Medical Products, Inc. (US), E. Benson Hood Laboratories, Inc. (US), Merit Medical Systems, Inc. (US), Cook Group (US), EFER ENDOSCOPY (France), ENDO-FLEX GmbH (Germany), Standard Sci. Tech Inc. (South Korea), and Stening SRL (Argentina), among others.

Browse Related Reports

Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

Bioresorbable Scaffold/Bioabsorbable Stents Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022

[marketanalysisdata]

Non-vascular Stents Market Analysis, Segments, Top Key Players, Drivers and Trends by Forecast to 2025

9th July 2021 – The global Non-Vascular Stents Market size is expected to value at USD 1.4 billion by 2025. The market is subject to witness a substantial growth due to the increase in geriatric population, upsurge in incidences related to chronic disorders, and rise in healthcare expenditure by local governments. Furthermore, growing importance towards minimally invasive surgeries across the globe is expected to drive growth of the market in upcoming years.

Increasing incidences related to the gastrointestinal cancer across the globe, is further propelling demand for non-vascular stents. Increase in the number of patients diagnosed with cancer are significantly influencing growth of the market. Globally, the market is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the non-vascular stents industry. Geriatric population is more susceptible towards chronic diseases including lung cancer, pancreatic cancer, colorectal cancer, and other diseases such as stroke, asthma. Subsequently, increasing incidences related to chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma, are responsible for rising demand of non-vascular stents.

Access Non-vascular Stents Market Report with TOC @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market

As per reports by World Health Organization (WHO), geriatric population is expected to reach two billion by 2050. Additionally, recent statistics presented by the American Cancer Society showcases as many as thirty thousand individuals suffering from stomach cancer in the North America region only. These factors are expected to fuel growth of the non-vascular stents market in coming years.

Rising adoption of the minimally invasive techniques such as nonvascular stenting is fueling the market growth of non-vascular stents. The minimally invasive techniques performed by tiny incisions instead of one large opening as they offer advantages such as quicker recovery times and less discomfort over traditional surgery. Additional advantages associated with adoption of minimally invasive techniques includes reduced pain during the surgery and minimum surgical scars. Reduction in the overall operational cost in comparison with traditional surgery techniques due to smaller incisions and minimum side effects, are propelling the demand of non-vascular stents industry.

The non-vascular stents market is majorly categorized into different market segments such as gastrointestinal stents segment, pulmonary, and urological stents segment. The gastrointestinal stents segment is considered as one of the fastest growing segment in the non-vascular stents industry with highest revenue generation in recent years. The gastrointestinal segment is further classified into different types such as biliary, pancreatic, and esophageal stents. Similarly, the pulmonary stents are also categorized into various types including silicone airway and metallic airway stents. Growing popularity of the urological stents segment is credited to the rise in occurrence of ureteral disorders such as renal calculi, kidney stone, urinary tract infections, and prostate cancer.

Non-vascular stents are commonly termed as a set of instruments that are specially designed for performing for a number of tasks involving biliary, bronchial and tracheal implantations. Rising application of the non-vascular stents is driving growth of the market. Non-vascular stents are utilized in order to improve prime patency in arteries and veins, which is commonly located at the site of stenotic. Non-vascular stents are classified into two common types such as balloon-expandable (BE) and self-expandable (SE).

The market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America and Europe have shown major growth in recent years owing to the rise adoption of latest methodologies for the treatment of chronic diseases and existence well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the non-vascular stents market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.

The key players in the non-vascular stents industry are Medtronic Co., C. R. Bard Incoporations, Boston Scientific Co., Ella Co., Conmed Co., Hobbs Medical Incorporations, Cook Medical Co., Taewoong Medical Corporations, Synchron Med Incorporations, and Glaukos Co.

Request a Sample Copy of Non-vascular Stents Market Report @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market/request-sample

[latestmarketresearchtrends-blog]

Non-vascular Stents Market Growth Analysis, Trends Forecast by Regions and Types to 2025

9th July 2021 – The global Non-Vascular Stents Market size is expected to value at USD 1.4 billion by 2025. The market is subject to witness a substantial growth due to the increase in geriatric population, upsurge in incidences related to chronic disorders, and rise in healthcare expenditure by local governments. Furthermore, growing importance towards minimally invasive surgeries across the globe is expected to drive growth of the market in upcoming years.

Increasing incidences related to the gastrointestinal cancer across the globe, is further propelling demand for non-vascular stents. Increase in the number of patients diagnosed with cancer are significantly influencing growth of the market. Globally, the market is predicted to grow at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the non-vascular stents industry. Geriatric population is more susceptible towards chronic diseases including lung cancer, pancreatic cancer, colorectal cancer, and other diseases such as stroke, asthma. Subsequently, increasing incidences related to chronic obstructive pulmonary disorders (COPD), chronic pancreatitis, prostate cancer, and glaucoma, are responsible for rising demand of non-vascular stents.

Access Non-vascular Stents Market Report with TOC @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market

As per reports by World Health Organization (WHO), geriatric population is expected to reach two billion by 2050. Additionally, recent statistics presented by the American Cancer Society showcases as many as thirty thousand individuals suffering from stomach cancer in the North America region only. These factors are expected to fuel growth of the non-vascular stents market in coming years.

Rising adoption of the minimally invasive techniques such as nonvascular stenting is fueling the market growth of non-vascular stents. The minimally invasive techniques performed by tiny incisions instead of one large opening as they offer advantages such as quicker recovery times and less discomfort over traditional surgery. Additional advantages associated with adoption of minimally invasive techniques includes reduced pain during the surgery and minimum surgical scars. Reduction in the overall operational cost in comparison with traditional surgery techniques due to smaller incisions and minimum side effects, are propelling the demand of non-vascular stents industry.

The non-vascular stents market is majorly categorized into different market segments such as gastrointestinal stents segment, pulmonary, and urological stents segment. The gastrointestinal stents segment is considered as one of the fastest growing segment in the non-vascular stents industry with highest revenue generation in recent years. The gastrointestinal segment is further classified into different types such as biliary, pancreatic, and esophageal stents. Similarly, the pulmonary stents are also categorized into various types including silicone airway and metallic airway stents. Growing popularity of the urological stents segment is credited to the rise in occurrence of ureteral disorders such as renal calculi, kidney stone, urinary tract infections, and prostate cancer.

Non-vascular stents are commonly termed as a set of instruments that are specially designed for performing for a number of tasks involving biliary, bronchial and tracheal implantations. Rising application of the non-vascular stents is driving growth of the market. Non-vascular stents are utilized in order to improve prime patency in arteries and veins, which is commonly located at the site of stenotic. Non-vascular stents are classified into two common types such as balloon-expandable (BE) and self-expandable (SE).

The market is divided into regional market segment such as North America, Europe, Asia-Pacific, Latin America and Africa. North America and Europe have shown major growth in recent years owing to the rise adoption of latest methodologies for the treatment of chronic diseases and existence well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the non-vascular stents market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with favorable government initiatives for use of such medical devices, rising geriatric population, and increasing healthcare expenditure.

The key players in the non-vascular stents industry are Medtronic Co., C. R. Bard Incoporations, Boston Scientific Co., Ella Co., Conmed Co., Hobbs Medical Incorporations, Cook Medical Co., Taewoong Medical Corporations, Synchron Med Incorporations, and Glaukos Co.

Request a Sample Copy of Non-vascular Stents Market Report @ https://www.millioninsights.com/industry-reports/non-vascular-stents-market/request-sample